| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President and COO | President and CEO
4 companies
Daniel N Swisher Jr. is President and CEO at VIRX and has filed Form 4s across 4 companies. From February 2015 to October 2025, the filings on record show 5 open-market purchases and 39 sales. Daniel N Swisher Jr.'s net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.1M at current prices.
Historically, Daniel N Swisher Jr.'s trades have earned a below-average insider score of 48/100 across 35 rated trades. Over a 12-month horizon, 27.3% of those trades were profitable, with an average 12-month return of -35.3%.
The biggest single holding is JAZZ (~$12.6M) as President and COO.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $22.11 | $48,642.00 | - | +6.5% | +106.8% | |
| Dec 1, 2023 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $25.47 | $56,034.00 | - | -9.5% | +122.1% | |
| Nov 1, 2023 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $27.96 | $61,512.00 | - | -22.1% | +74.3% | |
| Oct 2, 2023 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,200 | $27.32 | $60,104.00 | - | -8.1% | +77.8% | |
| Sep 5, 2023 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 3,750 | $32.83 | $123,111.50 | - | -17.0% | +9.4% | |
| Aug 7, 2023 | CORT Corcept Therapeutics Inc | Director | Sale+OE10b5-1 | 2,850 | $30.14 | $85,908.75 | - | -14.3% | +13.2% | |
| May 26, 2023 | CERS Cerus Corp | Director | Buy | 5,000 | $1.91 | $9,535.00 | +4.4% | -12.4% | -4.7% | |
| Nov 10, 2022 | CERS Cerus Corp | Director | Sale+OE | 12,500 | $3.91 | $48,875.00 | -9.9% | -23.1% | -59.9% | |
| Aug 8, 2022 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 15,385 | $28.32 | $435,703.20 | - | -12.4% | +7.5% | |
| Sep 2, 2021 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 7,500 | $21.70 | $162,741.00 | - | -2.6% | +18.0% |